Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 13.04%-303.8M | ---- | -59.62%-349.36M | ---- | 49.16%-218.87M | ---- | 7.30%-430.49M | ---- | -52.84%-464.39M |
| Profit adjustment | ||||||||||
| Attributable subsidiary (profit) loss | ---- | 52.29%65.53M | ---- | 0.63%43.03M | ---- | 95.23%42.76M | ---- | 198.66%21.9M | ---- | -18.07%7.33M |
| Impairment and provisions: | ---- | 199.02%70.7M | ---- | 193.42%23.64M | ---- | -84.15%8.06M | ---- | 275.20%50.84M | ---- | 639.63%13.55M |
| -Impairmen of inventory (reversal) | ---- | -83.36%2.62M | ---- | --15.76M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 142.86%2.96M | ---- | -84.18%1.22M | ---- | -84.86%7.7M | ---- | 275.20%50.84M | ---- | 639.63%13.55M |
| -Impairment of goodwill | ---- | --67.62M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -137.55%-2.5M | ---- | 1,755.99%6.66M | ---- | --359K | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -1,999.50%-22.68M | ---- | 104.15%1.19M | ---- | -109.38%-28.78M | ---- | 5.68%306.74M | ---- | 23.17%290.26M |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --306.74M | ---- | ---- |
| -Other fair value changes | ---- | -1,999.50%-22.68M | ---- | 104.15%1.19M | ---- | ---28.78M | ---- | ---- | ---- | 23.17%290.26M |
| Asset sale loss (gain): | ---- | 40.74%38K | ---- | -99.93%27K | ---- | 142.81%39.04M | ---- | -536,352.94%-91.2M | ---- | 97.33%-17K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.82%-19K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 40.74%38K | ---- | -99.93%27K | ---- | 79,579.59%39.04M | ---- | 2,350.00%49K | ---- | 105.13%2K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---91.25M | ---- | ---- |
| Depreciation and amortization: | ---- | 5.79%107.3M | ---- | 13.53%101.43M | ---- | 7.01%89.34M | ---- | -41.57%83.49M | ---- | 67.22%142.9M |
| -Amortization of intangible assets | ---- | 0.92%22.29M | ---- | 56.64%22.08M | ---- | -40.43%14.1M | ---- | -72.73%23.67M | ---- | 171.15%86.78M |
| -Other depreciation and amortization | ---- | 17.68%2.16M | ---- | -4.88%1.83M | ---- | -8.19%1.93M | ---- | -27.55%2.1M | ---- | 6.04%2.9M |
| Financial expense | ---- | -56.29%10.16M | ---- | 53.12%23.25M | ---- | 381.45%15.19M | ---- | -51.97%3.15M | ---- | -66.78%6.57M |
| Special items | ---- | -68.86%11.27M | ---- | -29.07%36.18M | ---- | 48.31%51.01M | ---- | 202.92%34.4M | ---- | --11.36M |
| Operating profit before the change of operating capital | ---- | 49.02%-61.48M | ---- | -5,257.57%-120.6M | ---- | 89.36%-2.25M | ---- | -380.02%-21.16M | ---- | -83.98%7.56M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -11.18%34.3M | ---- | 225.31%38.62M | ---- | -589.66%-30.82M | ---- | -351.92%-4.47M | ---- | 227.35%1.77M |
| Accounts receivable (increase)decrease | ---- | 79.97%-9.06M | ---- | -12.31%-45.25M | ---- | 4.88%-40.29M | ---- | 56.12%-42.36M | ---- | -644.87%-96.52M |
| Accounts payable increase (decrease) | ---- | -256.50%-72.42M | ---- | -18.68%46.28M | ---- | 319.62%56.91M | ---- | -115.24%-25.91M | ---- | 1,511.28%170.09M |
| Cash from business operations | -232.92%-118.16M | -34.23%-108.66M | -151.16%-35.49M | -392.10%-80.95M | 77.16%-14.13M | 82.48%-16.45M | -3.02%-61.88M | -213.27%-93.9M | -370.50%-60.06M | 91.03%82.9M |
| Special items of business | ---- | 80.53%-23.67M | ---- | 51.00%-121.56M | ---- | ---248.07M | ---- | ---- | ---- | ---- |
| Net cash from operations | -232.92%-118.16M | 34.66%-132.32M | -151.16%-35.49M | 23.44%-202.51M | 77.16%-14.13M | -181.70%-264.52M | -3.02%-61.88M | -213.27%-93.9M | -370.50%-60.06M | 91.03%82.9M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | ---- | ---- | ---- | ---- | ---- | -20.27%31.75M | --78.74M | --39.82M | ---- |
| Dividend received - investment | ---- | ---- | ---- | -89.01%378K | -85.12%378K | -27.70%3.44M | -14.85%2.54M | 431.03%4.76M | 234.53%2.98M | -79.19%896K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---45.4M | ---- | ---- |
| Decrease in deposits (increase) | 99.20%-43K | 138.80%46.68M | 93.68%-5.4M | -170.09%-120.29M | -684.73%-85.38M | 149.79%171.61M | 103.35%14.6M | -789.17%-344.68M | -87.53%-436.01M | ---38.76M |
| Sale of fixed assets | -95.97%22K | -45.45%6K | --546K | -98.70%11K | ---- | 1,124.64%845K | --290K | 115.63%69K | ---- | -31.91%32K |
| Purchase of fixed assets | 13.03%-27.5M | -82.49%-48.57M | -54.00%-31.62M | 0.26%-26.62M | 25.97%-20.54M | -859.27%-26.69M | -3,920.29%-27.74M | 92.90%-2.78M | 97.28%-690K | 36.37%-39.18M |
| Purchase of intangible assets | ---- | 33.39%-3.6M | ---- | -56.69%-5.41M | -320.24%-3.18M | 33.01%-3.45M | 77.86%-756K | 34.66%-5.15M | 36.59%-3.41M | -385.89%-7.89M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.17%19K |
| Recovery of cash from investments | ---- | -83.73%109.01M | ---- | -1.94%669.85M | -22.78%484.95M | 95.34%683.07M | 296.46%628M | -2.16%349.69M | -41.57%158.4M | 17.69%357.41M |
| Cash on investment | ---- | 66.48%-97.79M | ---- | 4.82%-291.74M | 83.03%-109.27M | 11.91%-306.52M | -320.31%-643.87M | ---347.97M | 49.67%-153.19M | ---- |
| Other items in the investment business | ---- | ---- | ---- | 108.54%35.67M | ---- | -2,460.47%-417.74M | ---- | 96.12%-16.32M | ---16.32M | -38.54%-420.48M |
| Adjustment items of investment business | --450K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 25.78%-27.07M | -97.81%5.73M | -113.66%-36.48M | 150.43%261.86M | 5,444.34%266.96M | 131.78%104.56M | 101.18%4.82M | -122.39%-329.04M | -38.16%-408.42M | 18.93%-147.96M |
| Net cash before financing | -101.80%-145.23M | -313.30%-126.59M | -128.47%-71.97M | 137.10%59.35M | 543.09%252.83M | 62.18%-159.96M | 87.82%-57.06M | -550.11%-422.94M | -71.35%-468.48M | 53.24%-65.06M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 98.77%207.08M | 28.81%335.55M | 35.22%104.18M | 306.24%260.5M | --77.04M | 781.32%64.13M | ---- | -68.43%7.28M | -95.12%777K | -70.61%23.05M |
| Refund | -33.26%-102.11M | -319.23%-258.38M | -1,056.97%-76.63M | -797.10%-61.63M | ---6.62M | 71.67%-6.87M | ---- | 68.72%-24.25M | 78.30%-16.83M | ---77.54M |
| Interest paid - financing | -11.15%-5.81M | -59.02%-10.05M | -132.77%-5.23M | -273.18%-6.32M | -434.76%-2.25M | -2.36%-1.69M | 45.24%-420K | 37.13%-1.65M | 41.67%-767K | -1.43%-2.63M |
| Absorb investment income | --2.18M | -77.31%1.63M | ---- | --7.19M | --4.45M | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 40.85%-94.79M | ---94.79M | ---160.27M | ---- | ---- | ---- | 3.68%-655K |
| Other items of the financing business | ---- | ---- | ---- | -52.94%-182K | ---- | 25.63%-119K | ---- | -49.53%-160K | ---- | 93.14%-107K |
| Net cash from financing operations | 462.94%100.45M | -32.39%62.81M | 157.03%17.84M | 180.44%92.9M | -1,790.51%-31.29M | -406.78%-115.49M | 91.14%-1.66M | 64.45%-22.79M | 71.80%-18.68M | -190.80%-64.11M |
| Effect of rate | 91.32%5.27M | 78.17%-3.65M | 110.29%2.75M | -123.54%-16.7M | -323.74%-26.76M | -196.95%-7.47M | -852.56%-6.31M | 718.04%7.71M | 146.40%839K | 85.86%-1.25M |
| Net Cash | 17.25%-44.79M | -141.90%-63.78M | -124.43%-54.13M | 155.27%152.25M | 477.32%221.54M | 38.20%-275.45M | 87.95%-58.72M | -245.10%-445.73M | -43.42%-487.16M | -88.51%-129.16M |
| Begining period cash | -16.93%330.96M | 51.57%398.39M | 51.57%398.39M | -51.84%262.85M | -51.84%262.85M | -44.52%545.77M | -44.52%545.77M | -11.70%983.79M | -11.70%983.79M | -6.49%1.11B |
| Cash at the end | -16.02%291.44M | -16.93%330.96M | -24.17%347.02M | 51.57%398.39M | -4.81%457.63M | -51.84%262.85M | -3.36%480.74M | -44.52%545.77M | -35.62%497.47M | -11.70%983.79M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.